Neuroendocrine changes in systemic lupus erythematosus and Sjogren's syndrome

Bailliere's Clinical Rheumatology

Volumn 10, Issue 2, 1996, Pages 333-347

  Fox, R A ^a   Moore, P M ^a   Isenberg, D A ^a  

^a WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; PROGESTERONE; PROLACTIN; SEX HORMONE;

AUTOIMMUNITY; ETIOLOGY; EXOCRINE GLAND; FEMALE; HORMONE METABOLISM; HUMAN; IMMUNOMODULATION; MALE; MOUSE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029935927     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(96)80020-3     Document Type: Article

References (96)

1. Ahmed SA & Talal N (1990) Sex hormones and the immune system Part 2. Animal data. Baillikrès Clinical Rheumatology 4: 13-31.
2. Ahmed SA, Penhale W J, Talal N (1985) Sex hormones, immune responses and autoimmune diseases. Mechanism of sex hormone action. American Journal of Pathology 121:531-551.
3. Ahmed SA, Dauphinee MJ, Montoya IA & Talal N (1989a) Oestrogen induces normal murine CD5+ B cells to produce autoantibodies. Journal oflmmunology 142: 2647-2653.
4. Ahmed SA, Aufdemorte TB, Chen JR et al (1989b) Oestrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates in normal mice. Journal of Autoimmunity 2: 543-552.
5. Andrews B, Eisenberg R, Theofilopoulos Aet al (1978) Spontaneous marine lupus like syndromes. Journal of Experimental Medicine 148: 1198-1215.
6. Appelmans M (1948) La kerr atto-conjonctivite seche de Gougerot-Sjrgren. Archives Opthalmologie (Paris) 81: 577-588.
7. Ariga H, Edwards J & Sullivan DA (1989) Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-1 pr/1 pr mice. Clinical Immunology and Immunopathology 53: 499-508.
8. Amalich F, Benito-Urbina S, Gonzalez-Gancedo Pet al (1992) Inadequate production of progesterone in women with systemic lupus erythematosus. British Journal of Rheumatology 31: 247-251.
9. Athreya BH, Pletcher J, Zulian F et al (1993) Subset specific effects of sex hormones and pituitary gonadotropins on hmnan lymphocyte proliferation in vitro. Clinical Immunology and Immunopathology 66:201-211.
10. Azad N, La Paglia N, Jurgens AJ et al (1993) Immunoactivation enhances the concentration of luteinizing hormone releasing hormone peptide and its gene expression in human peripheral T lymphocytes. Endocrinology 133: 215-223.
11. Batticane N, Morale MC, Gallo F et al (1991) Luteinizing hormone releasing hormone signaling at the lymphocyte involves stimulation of IL2 receptor expression. Endocrinology 129: 277-280.
12. Bhoola KD, Dorey G & Jones CW (1973) The influence of androgens on enzymes (chymotrypsinand trypsin like proteases, renin, kallikrein and amylase) and on cellular structure of the mouse submaxillary gland. Journal of Physiology 235: 503-522.
13. Bizzaro A, Valentini G, Di Martino Get al (1987) Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. Journal of Clinical Endocrinology and Metabolism 64: 32-36.
14. Brick JE, Wilson DA & Walker SE (1985) Hormonal modulation of responses to thymic independent and thymic dependent antigens in patients with systemic lupus erythematosus. Clinical and Experimental Immunology 136: 3693-3698.
15. Bruckner R (1945) Uber einem erfolgreich mit perandren benhandelten fall yon Sjrgren'schem symptomen komplex. Opthalmologica 110: 37-42.
16. Bucala R, Lahita RG, Fishman J & Cerani A (1987) Antioestrogen antibodies in users of oral contraceptives and in patients with systemic lupus erythematosus. Clinical and Experimental Immunology 67: 167-175.
17. Carlsten H, Tarkowsld A, Holmdahl R & Nilsson LA (1990) Oestrogen is a potent disease accelerator in SLE prone MRL lpr/lpr mice. Clinical and Experimental Immunology 80: 467-473.
18. Carlsten H, Nilsson N, Jonsson R et al (1992) Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell mediated vasculitis and sialadenitis in autoimmune MRL 1 pr/lpr mice. Cellular Immunology 144: 190-202.
19. Cheung CY (1983) Prolactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone releasing hormone by a direct action at the anterior pituitary. Endocrinology 112: 632-638.
20. Cohen JHM, Daniel L, Cordier Get al (1983) Sex steroid receptors in peripheral T cells, absence of androgen receptors and restriction of estrogen receptors to OKT8 positive cells. Journal of Immunology 131: 2767-2771.
21. Conconi MV & Walker AM (1984) Chloroquine affects prolactin secretion and Golgi morphology in the marnmotroph. Endocrinology 114: 725-734.
22. Counihan KA, Vertosick FT & Kelly RH (1991) Antioestrogen antibodies in systemic lupus erythematosus. A quantitative evaluation of serum levels. Immunological Investigations 20:317-331.
23. Czinn SJ & Lamm ME (1986) Selective chemotaxis of subsets of B lymphocytes from gut associated lymphoid tissue and its implication for the recruitment of mucosal plasma cells. Journal of Immunology 136:3607-3611.
24. Dauphinee MJ, Tovar Z & Talal N (1988) B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis and Rheumatism 31: 642-647.
25. Dinarello CA & Wolff SM (1993) The role of interleukin-1 in disease. New England Journal of Medicine 328: 106-113.
26. Fox RI & Saito I (1994) Sjrgren's syndrome: immunologic and neuroendocrine mechanisms. Advances in Experimental Medicine and Biology 350: 609-621.
27. Galbralth RA & Michnovicz JJ (1989) The effects of cimetidine on the oxidative metabolism of oestradiol. New England Journal of Medicine 321: 269-274.
28. Goldstein AL, Low TLK, Thurman GB et al (1981) Current status of thymosin and other hormones of the thymus gland. Recent Progress in Hormone Research 37: 369-415.
29. Goldsteyn EJ & Fritzler MJ (1987) Review: the role of the thymus-hypothalamus-pituitarygonadal axis in normal immune processes and autoimmunity. Journal of Rheumatology 14:982-990.
30. Grossman C J, Sholiton LJ & Nathan P (1979) Rat thymic estrogen receptor: I: Preparation, location and physiochemical properties. Journal of Steroid Biochemistry 11: 1233-1240.
31. Grossman CJ, Sholiton LJ & Helmsworth JA (1983) Characteritics of the cytoplasmic and nuclear dihydrotestosterone receptors of human thymic tissues. Steroids 42: 11-22.
32. Guitierrez-Ramos JC, Andrew JL, Revilla et al (1990) Recovery from autoimmunity of MRL/Ipr mice after infection with an interleukin 2/vaccinia recombinant virus. Nature 346: 271-274.
33. Hannappel E, Xu GJ, Morgan Jet al (1982) Thymosin B4: A ubiquitous peptide in rat and mouse tissue. Proceedings of the Nafional Academy of Sciences, USA 79: 2172-2175.
34. Hellerstein MK, Meydani SN, Meydani Met al (1989) Interleukin-1 induced anorexia in the rat. Influence of prostaglandins. Journal of Clinical Investigation 84: 228-235.
35. Hirohata S & Miyamoto T (1990) Elevated levels of interleukin-6 in cerebrospinal fluid of patients with systemic lupus erythematosus and central nervous system involvement. Arthritis and Rheumatism 33" 644-649.
36. Holdstock G, Chastenay BF & Krawitt EL (1982) Effects of testosterone, oestradiol and progesterone on immune regulation. Clinical and Experimental Immunology 47: 449-456.
37. Howie JB & Helyer BJ (1968) The immunology and pathology of NZB mice. Advances in Immunology 9: 215-266.
38. Hu Y, Dietrich H, Herold Met al (1993) Disturbed immuno endocrine communications via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Internal Archives of Allergy and Immunology 102: 232-241.
39. Hulka JF, Mohr H & Lieberman MW (1965) Effects of synthetic progestational agents on allograft rejection and circulating antibody production. Endocrinology 77: 897-903.
40. Inman RD (1978) Immunologic sex differences and the female preponderence of systemic lupus erythematosus. Arthritis and Rheumatism 21: 849-852.
41. Isenberg DA, Rowe D, Tookman A et al (1984) An immunohistological study of secondary Sjögren's syndrome. Annals of Rheumatic Disease 43" 470-476.
42. Jacobsen JD, Nisula BC & Steinberg AD (1994) Modulation of the expression of murine lupus by Gonadotropin releasing hormone analogs. Endocrinology 134: 2516-2523.
43. Jara LJ, Graef A & Lavalle C (1991) Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. Journal of Rheumatology 18: 349-353.
44. Jara LJ, Gomez-Sanchez C, Silveira LH et al (1992) Hyperprolactinaemia in systemic lupus erythematosus. Association with disease activity. American Journal of the Medical Sciences 303:222-226.
45. Julkunen HA (1991) Oral contraceptives in systemic lupus erythematosus: side effects and the influence on the activity of SLE. Scandinavian Journal of Rheumatology 20: 427-433.
46. Jungers P, Dougados M, Pelissier C et al (1982) Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis and Rheumatism 25:618-623.
47. Kind FA & Ciacco LA (1980) Suppression of immune response by progesterone. Endocrinologia Experimentalis 14: 27-32.
48. Kumagami H & Onitsuka T (1993) Estradiol and testosterone in minor salivary glands of Sjögren's syndrome. Auris Nasus-Larynx (Tokyo) 20: 137-143.
49. Lahita RG & Bradlow HL (1987) Klinefelter's syndrome: hormone metabolism in hypogonadal males with systemic lupus erythematosus. Journal of Rheumatology 14: 154-157.
50. Lahita RG, Bradlow HL, Kunkel HG & Fishman J (1979) Alterations of oestrogen metabolism in systemic lupus erythematosus. Arthritis and Rheumatism 22:1195-1198.
51. Lahita RG, Bradlow HL, Kunkel HG & Fishman J (1983) Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis and Rheumatism 26: 1517-1521.
52. Lahita RG, Bradlow HL, Ginzler E et al (1987) Low plasma androgens in women with systemic lupus erythematosus. Arthritis and Rheumatism 30: 241-248.
53. Lavalle C, Gonzalez-Barcena D, Graef A & Fraga A (1984) Gonadotropin pituitary secretion in systemic lupus erythematosus. Clinical and Experimental RheumatoIogy 2: 163-165.
54. Lavalle C, Loyo E, Paniagua R et al (1987) Correlation study between prolactin and androgens in male patients with SLE. Journal of Rheumatology 14: 268-272.
55. Lehar SC, Settineri SM & Kelly RH (1987) Antihormonal and antinuclear (ANA) responses of mice immunised with estradiol. Immunological Investigations 16:117-128.
56. Leonard JP, MacKenzie FJ, Patel HA et al (1991) Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis. Brain and Behavioural Immunology 5: 328-338.
57. Luster MI, Hayes HT, Korach K et al (1984) Estrogen immunosuppression is regulated through estrogen responses in the thymus. Journal of Immunology 133: 111-116.
58. Marchetti B, Guarcello V, Morale MC et al (1989) Luteinizing hormone releasing hormone (LHRH) agonist restoration of age associated decline of thymus weight, thymic LHRH receptors and thymocyte proliferative capacity. Endocrinology 125:1037-1045.
59. Matta S, Weatherbee J & Sharp BM (1992) A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to an interaction with IL-1B. Neuroendocrinology 56:516-525.
60. McMurray R, Keisler D, lzui S & Walker SE (1994) Hyperprolactinaemia in male NZB/NZW (B/W) F1 mice. Accelerated autoimmune disease with normal circulating testosterone. Clinical Immunology and lmmunopathology 71: 338-343.
61. Moinuddin & Ali A (1994) SLE anti-DNA autoantibodies binding estradiol-albumin-DNA conjugate. Lupus 3: 43-46.
62. Morale MC, Batticane N, Bartoloni Get al (1991) Blockade of central and peripheral luteinizing hormone releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH antagonist inhibits the morphofuctional development of the thymus and maturation of the cell mediated and humoral immune responses. Endocrinology 128: 1074-1085.
63. Mori T, Kobayashi H, Nishimoto H et al (1977) Inhibitory effects of progesterone and 20 hydroxypreg-4-en-3 one on the phytohaemagglutinin induced transformation of human lymphocytes. American Journal of Obstetrics and Gynaecology 127: 151-159.
64. Mukherjee E Mastro AM & Hymer WC (1990) Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 126: 88-94.
65. Munoz JA, Gil A, Lopez-Dupla JM et al (1994) Sex hormones in chronic systemic lupus erythematosus. Annales de Medecine Interne (Paris) 147: 459-463.
66. Murakawa Y, Takada S, Ueda Y et al (1985) Characterization of T lymphocyte sub populations responsible for deficient interleakin 2 activity in patients with systemic lupus erythematosus. Journal of Immunology 134: 187-195.
67. Navarra P, Tsagarakis S, Faria MS et al (1991) Interleukins-1 and-6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128: 37-44.
68. Novotny EA, Raveche ES, Sharrow Set al (1983) Analysis of thymocyte subpopulation following treatment with sex hormone. Clinical Immunology and lmmunopathology 28: 205-217.
69. Ota M, Kyakumoto S & Nernoto T (1985) Demonstration and characterisation of cytosol androgen receptor in rat exorbital lacrimal gland. Biochemistry International 13:671-679.
70. Paavonen T, Anderson LC & Adlercreutz H (1981) Sex hormone regulation of in vitro response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen stimulated cultures. Journal of Experimental Medicine 154: 1935-1945.
71. Rabinovich CE, Schamberg L & Kredich D (1990) Intravenous immunoglobnlin and bromocryptine in the treatment of refractory neuropsychiatric SLE. Arthritis and Rheumatism 33 (supplement): R22 (Abstract 495).
72. Rebar RW, Miyake A, Low TLK et al (1981) Thymosin stimulates secretion of luteinizing hormone releasing factor. Science 214: 669-671.
73. Russell DH, Kibler R, Matrisian L et al (1985) Prolactin receptors on human T and B lymphocytes; antagonism of prolactin binding by cyclosporine. Journal of Immunology 134:3027-3031.
74. Sato EH, Ariga H & Sullivan DA (1992) Impact of androgen therapy in Sjögren's syndrome. Hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Investigative Opthalmology and Visual Science 33: 2537-2545.
75. Sequeira JF, Keser G, Greenstein Bet al (1993) Systemic lupus erythematosus: sex hormones in male patients. Lupus 2: 315-317.
76. Siiteri PK, Jones LA, Rubinian JR & Talal N (1980) Sex steroids and the immune system-I. Sex differences in autoimmune disease in NZB/NZW hybrid mice. Journal of Steroid Biochemistry 12: 425-432.
77. Speight PM & Jordan R (1994) The molecular pathology of Sjögren's syndrome. In Isenberg DA & Horsfall AC (eds) Autoimmune Diseases, Focus on SjOgren's syndrome, pp 25-42. Oxford: Bios Scientific Publishers.
78. Stahl NI & Decker JL (1978)Androgenic status of males with systemic lupus erythematosus. Arthritis and Rheumatism 21: 665-668.
79. Steinberg AD, Roths JB, Murphy ED et al (1980) Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. Journal oflmmunology 125:871-873.
80. Sternberg EM, Chrousos GP, Wilder RL & Gold PW (1992) The stress response and the regulation of inflammatory disease. Annals of Internal Medicine 117: 854-866.
81. Suda T, Tozawa F, Ushiyama T et al (1990) Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology 126: 1223-1228.
82. Sullivan DA (1988) Influence of the hypothalamic-pitnitary axis on the androgen regulation of the ocular secretory immune system. Journal of Steroid Biochemistry 30: 429-433.
83. Sullivan DA & Sato Eli (1992) Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in SjSgren's syndrome. Clinical Immunology and lmmunopathology 64: 9-16.
84. Sundar SK, Cierpial MA, Kilts C et al (1990) Brain IL-1 induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropinreleasing factor. Journal of Neuroscience 10: 3701-3706.
85. Sutton RE, Koob GF, Le Moal Met al (1982) Corticotropin releasing factor produces behavioural activation in rats. Nature 29: 331-333.
86. Suzuki T, Suzuki N, Engleman EG et al (1995) Low serum levels of dehydroepiandrosterone may cause deficient IL2 production by lymphocytes in patients with systemic lupus erythematosus. Clinical and Experimental Immunology 99: 251-255.
87. Talal N, Dauphinee MJ & Wofsy D (1982) Interleukin-2 deficiency genes and systemic lupus erythematosus. Arthritis and Rheumatism 25: 838-842.
88. Tehrani MJ, Hugh Y, Marquette C et al (1994) Interleukin-1 receptor deficiency in brains from NZB and (NZB/NZW) F1 autoimmune mice. Journal of Neuroimmunology 53" 91-99.
89. Tsai CY, Wu TH, Tsai ST et al (1994) Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections. Scandinavian Journal of Rheumatology 23: 57-63.
90. Tzionfas AG & Skopouli FN (1995) Immunopathology of Sjögren's syndrome. Rheumatology in Europe 24: 57-59.
91. Van Vollenhoven RF, Engleman EG & McGuire JL (1994) An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis and Rheumatism 37:1305-1310.
92. Walker SE, Besch-Willford CL & Keisler DH (1994) Accelerated deaths from systemic lupus erythematosus in NZB x NZW F1 mice treated with the testosterone blocking drug flutamide. Journal of Laboratory and Clinical Medicine 124: 401-407.
93. Weigent DA & Blalock JE (1987) Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunological Reviews 100: 79-108.
94. Weinstein Y & Berkovich Z (1981) Testosterone effect on bone marrow, thymus and suppressor T cells in the (NZB x NZW) F1 mice. Its relevance to autoimmunity. Journal oflmmunology 126: 998-1002.
95. Wilson T & Christie DL (1991) Gravidin, an endogenous inhibitor of phospholipase A2 activity is a secretory component of IgA. Biochemical and Biophysical Research Communications 176-447-452.
96. Zurier RB (1975) Systemic lupus erythematosus and pregnancy. Clinics in Rheumatic Disease 1: 613-620.